🎙️ The latest episode of the SMA My Way podcast is live! 🌟 Join Martyn and Josh as they dig into the resilience and strength of individuals navigating the world of travel amid physical limitations, shedding light on the obstacles they have overcome. 🌍 ✈️ Discover how adversity within the travel industry can often lead to the most profound growth and unforgettable memories. Search “SMA My Way” in your preferred podcast streaming platform or click here to listen on Spotify 👉 http://spkl.io/60474hPex
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
🛣️ Your way - Be part of something bigger! Become part of a company that strives for success while prioritizing humanity and diversity 👥 Experience a dynamic community that values every voice and fosters a culture of collaboration and innovation. Join us, where your contributions make a real impact, and together we build a future that's inclusive and inspiring. Find more information about working at Roche: https://lnkd.in/eUU8W6M5
-
Despite significant progress in lung cancer diagnosis and treatment over the last 20 years, we still have a long way to go to ensure every person with lung cancer gets the care they need. Our teams are working tirelessly to expand our understanding of how lung cancer operates and discover potential new ways to tackle it. But this is just one piece of the puzzle - continued collaboration across the community is vital to making a difference for patients. On World Lung Cancer Day, we want to recognise and thank our partners in the lung cancer community as we continue to redefine lung cancer together to support people with lung cancer at every stage of their journey. Learn more: http://spkl.io/60454hJE3
-
We are pleased to announce today the completion of the acquisition of LumiraDx’s Point of Care technology, enabling us to further accelerate innovation in near-patient care. It will also help to expand patient access to timely diagnostics results in community-based care, especially in low and middle-income countries.
-
In a world where #hepatitis testing and treatment have been made more accessible, what’s stopping people from getting tested? Societal attitudes and taboos not only discourage individuals from seeking testing, but also perpetuates a harmful culture of silence and blame surrounding the disease. Many people are reluctant to get screened for the fear of being labeled as someone “who deserves it”. The reality is anybody can get hepatitis, but nobody deserves it. In a social experiment we conducted, four people bravely shared their diagnosis. However, millions continue to live in silence. We believe everyone deserves to get tested. By shining a light on hepatitis we can move closer to achieving the World Health Organization 2030 hepatitis elimination goals. Learn more: http://spkl.io/60404C4q0 #WorldHepatitisDay
-
🚀 We are driving innovation to create new solutions for those living with #Alzheimer's disease. Our unwavering commitment to advancing diagnostic capabilities and pioneering therapeutic strategies shows our dedication to every aspect of the patient journey in #Alzheimer’s disease. Discover all scientific advancements from diagnostics to therapeutics in the link below, join the conversation, and learn more about Roche’s bold vision to improve the lives of people living with Alzheimer’s disease. 🧠🔬 👉 http://spkl.io/60494Cvfl
-
🌟 Meet Ömer Faruk Öz: Engineering a Sustainable Future at Roche 🌟 From the chemical industry to healthcare innovation, Ömer leverages his skills to drive impactful, sustainable solutions at Roche, contributing significantly to our 2050 climate goals. 🚀 Ready to be inspired? Learn more about our mission and explore opportunities to join us! » go.roche.com/internshipli #Roche #Sustainability #HealthcareInnovation #CareerJourney #IP2TIS
-
Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised. For more details on our performance, click here ➡️ http://spkl.io/60424CQde
-
#DYK as of 2022, 354 million people globally were living with chronic Hepatitis B or C virus infection. Of those living with viral hepatitis over 80% had not been treated. Recently, John Ward, Director of the Coalition for Global Hepatitis Elimination, spoke about why #hepatitis is often referred to as the “silent dragon”, and the importance of testing, diagnosis, and early treatment in preventing many Hepatitis-related deaths worldwide that could have been avoided. To find out more, watch the full panel discussion: http://spkl.io/60444CSRr
-
Each person with cancer is unique, so different types of treatment administration, where available, may help to meet different patients’ needs and lifestyles. 👇 Healthcare professionals can share our discussion guide with their patients to enhance conversations about cancer care. Click here to learn more and download our discussion guide: http://spkl.io/60414CuNv
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Letzte Runde
Kapitalerhöhung nach Börsengang5.000.000.000,00 $
Investor:innen
SoftBank